Probiotic administration as add-on therapy in ulcerative colitis and pouchitis.


A probiotic strain (Bifidobacterium breveĀ UCP0911) was selected with anti-inflammatory properties and hence, important potential in the treatment of inflammatory bowel disease (IBD). During well-designed clinical trials, the potential of the selected probiotic in IBD patients (ulcerative colitis and pouchitis) will be fully explored. These clinical trials will aim at unravelling the basic interaction between microbial, immunological and genetic parameters in correlation with the clinical outcome, based on a rational multidisciplinary approach.

Run time: 
01/10/2007 to 31/12/2011
Project titel (NL): 
Probiotische inname als toegevoegde therapie voor colitis ulcerosa en pouchitis.
Project omschrijving (NL): 

Geen Nederlandse beschrijving.